In contrast, in type 2 diabetes,the insulinotropic and glucagonostatic effects of GLP-1 dominate theglucose-lowering profile; meanwhile, the addition of Gcg activity enhances weightloss and hepatic lipid turnover—two key drivers of insulin resistance. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.